Seeing Is Believing
Currently out of the existing stock ratings of Gary Nachman, 162 are a BUY (67.78%), 76 are a HOLD (31.8%), 1 are a SELL (0.42%).
Analyst Gary Nachman works at RAYMOND JAMES with a stock forecast success ratio of 36.12% fulfilled within 109.79 days on average. Previously, Gary Nachman worked at BMO.
Gary Nachmanās has documented 494 price targets and ratings displayed on 28 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on AQST, Aquestive Therapeutics at 28-Mar-2024.
Analyst best performing recommendations are on LCI (LANNETT COMPANY).
The best stock recommendation documented was for MNK (MALLINCKRODT PLC) at 9/5/2019. The price target of $3 was fulfilled within 5 days with a profit of $1.41 (88.68%) receiving and performance score of 177.36.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
71
$29.95 (72.96%)
41
8 months 9 days ago
10/11 (90.91%)
$8.79 (14.13%)
337
Buy
70
$28.95 (70.52%)
44
8 months 24 days ago
2/3 (66.67%)
$8.35 (13.54%)
105
Hold
44
$2.95 (7.19%)
40
11 months 1 days ago
5/5 (100%)
$1.03 (2.40%)
86
Buy
33
$-25.16 (-43.26%)
24
2 years 1 months 7 days ago
3/3 (100%)
$-1.3 (-3.79%)
375
Hold
3 years 9 months 9 days ago
2/2 (100%)
$5.8 (47.54%)
224
Which stock is Gary Nachman is most bullish on?
Which stock is Gary Nachman is most reserved on?
What Year was the first public recommendation made by Gary Nachman?